Status:
COMPLETED
The PediQUEST Response Intervention Study
Lead Sponsor:
Joanne Wolfe, MD, MPH
Collaborating Sponsors:
Children's Hospital of Philadelphia
Seattle Children's Hospital
Conditions:
Advanced Cancer
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
PediQUEST Response proposes a new system of care that expects to improve quality of life in children, adolescents, and young adults with advanced cancer and their parents. The investigators want to le...
Detailed Description
Background: Integration of palliative care (PC) has been associated with better health related quality of life (HRQoL) and longer survival in adults and their caregivers. Yet, only a few randomized co...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Pediatric oncology patients (children, adolescents, or young adults), and one of their parents, receiving routine cancer care at one of the participating centers -and not in remission and off cancer-directed treatment-that have:
- (i) advanced cancer defined as: at least a 2-week history of progressive, recurrent, or non-responsive cancer of any type, or any brainstem tumor, or a grade IV Glioblastoma Multiforme, or decision not to pursue cancer-directed therapy in place, or or any other progressive/recurrent solid or brain tumor, and are
- (ii) palliative care naive, defined as the palliative care team not currently integrated into their regular cancer care.
- Exclusion criteria:
- The patient-parent dyad would be excluded if
- patients are older than 18 years of age and no parent is involved in his/her care, or
- if patient is under the care of foster parents who do not have legal guardianship, or
- if both parents do not speak English or Spanish, or are unable to understand and complete surveys, or
- if the patient has a non-brainstem low-grade glioma with localized progression/relapse only, or
- is expected to receive a stem cell transplant within the next 18 weeks, or
- life expectancy is less than two months.
Exclusion
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2022
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT03408314
Start Date
March 1 2018
End Date
September 14 2022
Last Update
November 29 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611
2
Boston Children's Hospital
Boston, Massachusetts, United States, 02215
3
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215
4
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104-4318